Cargando…

Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases()

Mutations in LRRK2 are the most common genetic cause of Parkinson's disease (PD). The most prevalent LRRK2 mutation is the G2019S coding change, located in the kinase domain of this complex multi-domain protein. The majority of G2019S autopsy cases feature typical Lewy Body pathology with a cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mamais, Adamantios, Raja, Meera, Manzoni, Claudia, Dihanich, Sybille, Lees, Andrew, Moore, Darren, Lewis, Patrick A., Bandopadhyay, Rina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752970/ https://www.ncbi.nlm.nih.gov/pubmed/23747310 http://dx.doi.org/10.1016/j.nbd.2013.05.017

Ejemplares similares

Inhibition of LRRK2 kinase activity stimulates macroautophagy()
por: Manzoni, Claudia, et al.
Publicado: (2013)

GTP binding controls complex formation by the human ROCO protein MASL1
por: Dihanich, Sybille, et al.
Publicado: (2014)

Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson’s disease brains with Lewy body pathology
por: Mamais, Adamantios, et al.
Publicado: (2018)

mTOR independent alteration in ULK1 Ser758 phosphorylation following chronic LRRK2 kinase inhibition
por: Manzoni, Claudia, et al.
Publicado: (2018)

Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation()
por: Manzoni, Claudia, et al.
Publicado: (2013)

Differential LRRK2 signalling and gene expression in WT-LRRK2 and G2019S-LRRK2 mouse microglia treated with zymosan and MLi2
por: Nazish, Iqra, et al.
Publicado: (2023)

Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations
por: Trancikova, Alzbeta, et al.
Publicado: (2012)

mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1
por: Manzoni, Claudia, et al.
Publicado: (2016)

Cellular processes associated with LRRK2 function and dysfunction
por: Wallings, Rebecca, et al.
Publicado: (2015)

Arsenite Stress Down-regulates Phosphorylation and 14-3-3 Binding of Leucine-rich Repeat Kinase 2 (LRRK2), Promoting Self-association and Cellular Redistribution
por: Mamais, Adamantios, et al.
Publicado: (2014)

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
por: Bandopadhyay, Rina
Publicado: (2016)

Perspective on the current state of the LRRK2 field
por: Taymans, Jean-Marc, et al.
Publicado: (2023)

Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo
por: Kluss, Jillian H., et al.
Publicado: (2021)

Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue
por: Devine, Michael J., et al.
Publicado: (2011)

Neuron-autonomous susceptibility to induced synuclein aggregation is exacerbated by endogenous Lrrk2 mutations and ameliorated by Lrrk2 genetic knock-out
por: MacIsaac, Sarah, et al.
Publicado: (2020)

Correction: Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue
por: Devine, Michael J., et al.
Publicado: (2012)

Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity
por: Kluss, Jillian H., et al.
Publicado: (2018)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice
por: Uemura, Norihito, et al.
Publicado: (2023)

LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
por: O’Hara, Darren M., et al.
Publicado: (2020)

A toxic subset of soluble α-synuclein species in dementia with Lewy body
por: Castillo-Carranza, Diana L
Publicado: (2020)

Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
por: Leitão, André D. G., et al.
Publicado: (2021)

LRRK2 in Parkinson's disease and dementia with Lewy bodies
por: Zhu, Xiongwei, et al.
Publicado: (2006)

Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia
por: Mamais, Adamantios, et al.
Publicado: (2021)

LRRK2 mediates tubulation and vesicle sorting from lysosomes
por: Bonet-Ponce, Luis, et al.
Publicado: (2020)

The Role of α-Synuclein and LRRK2 in Tau Phosphorylation
por: Kawakami, Fumitaka, et al.
Publicado: (2015)

Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 Locus
por: Trabzuni, Daniah, et al.
Publicado: (2013)

Correction: Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia
por: Mamais, Adamantios, et al.
Publicado: (2022)

In silico comparative analysis of LRRK2 interactomes from brain, kidney and lung
por: Verma, Amrita, et al.
Publicado: (2021)

TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT()
por: Ling, Helen, et al.
Publicado: (2013)

Formation of α-synuclein Lewy neurite–like aggregates in axons impedes the transport of distinct endosomes
por: Volpicelli-Daley, Laura A., et al.
Publicado: (2014)

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease
por: Emin, Derya, et al.
Publicado: (2022)

Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7
por: Chia, Ruth, et al.
Publicado: (2014)

Epitope Mapping of Antibodies to Alpha-Synuclein in LRRK2 Mutation Carriers, Idiopathic Parkinson Disease Patients, and Healthy Controls
por: Alvarez-Castelao, Beatriz, et al.
Publicado: (2014)

Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease()
por: Dunn, Laura, et al.
Publicado: (2014)

Sequential screening nominates the Parkinson's disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosis
por: Heaton, George R., et al.
Publicado: (2020)

Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily
por: Stafa, Klodjan, et al.
Publicado: (2014)

LRRK2 and Protein Aggregation in Parkinson’s Disease: Insights From Animal Models
por: Dues, Dylan J., et al.
Publicado: (2020)

Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2
por: Dues, Dylan J., et al.
Publicado: (2023)

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
por: Schulz-Schaeffer, Walter J.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_sp1g7njl5rnoj9i602f2v991do